Malcolm Allison is a highly accomplished pharmaceutical marketing executive with over 40 years of international experience across leading global healthcare organizations. He brings deep expertise in product launches, strategic brand development, and lifecycle management across multiple therapeutic areas, including cardiovascular disease, oncology, and diabetes.

​

Throughout his career, Malcolm has held senior leadership roles at companies such as Bayer, Novartis, and Actelion, where he consistently delivered successful product strategies, turnaround initiatives, and above-target commercial performance. As Owner and Director of InterComm, he has continued to advise healthcare companies on early-stage assets and strategic communications.

​

As a member of the SynapCon Advisory Board, Malcolm provides strategic guidance, leveraging his extensive industry knowledge, leadership experience, and ability to translate complex scientific data into compelling, differentiated value propositions that drive growth and innovation.